# A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting

> **NCT01664104** · — · COMPLETED · sponsor: **Hoffmann-La Roche** · enrollment: 151 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** Tocilizumab

## Key facts

- **NCT ID:** NCT01664104
- **Lead sponsor:** Hoffmann-La Roche
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2012-06
- **Primary completion:** 2013-12
- **Final completion:** 2013-12
- **Target enrollment:** 151 (ACTUAL)
- **Last updated:** 2017-07-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01664104

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01664104, "A Study to Evaluate Tocilizumab Treatment in a Real-Life Setting". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01664104. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*